![]() |
市場調查報告書
商品編碼
2068770
人工智慧在健康保險理賠管理市場的市場預測—全球分析(按組件、技術、理賠類型、功能、應用、最終用戶和地區分類)—2034年AI in Healthcare Claims Management Market Forecasts to 2034 - Global Analysis By Component (Software and Services), Technology, Claims Type, Function, Application, End User and By Geography |
||||||
全球健康保險理賠管理人工智慧市場預計到 2026 年將達到 41 億美元,到 2034 年將達到 186 億美元,預測期內複合年成長率為 20.7%。
人工智慧在醫療保健理賠管理中的應用,是指利用機器學習、自然語言處理和機器人流程自動化 (RPA) 技術,實現醫療保健機構、藥房、牙科診所和醫院的保險理賠流程的自動化、檢驗和最佳化。這些解決方案能夠縮短審核週期、降低管理成本、偵測詐欺性理賠,並提高理賠拒賠預測的準確性。
保險理賠激增,給保險公司和醫療機構帶來了行政成本壓力。
全球醫療保健系統每年處理數十億份保險索賠,其中行政成本在醫療保健總支出中佔比過高。人工審核索賠本身就容易出錯、耗費人力,且有合規風險。人工智慧平台透過自動化資料檢驗和智慧編碼輔助來提高準確性,同時將處理時間從數天大幅縮短至數分鐘。面臨利潤率壓力的保險公司和飽受高拒賠率困擾的醫療機構正擴大採用人工智慧解決方案來簡化收入週期、加快現金流,並將熟練的員工重新分配到更高價值的任務中。
資料隱私問題和複雜的監管合規要求
醫療保健理賠資料是最敏感的個人資訊類別之一,受到包括美國 HIPAA 和歐洲 GDPR 在內的嚴格資料保護框架的約束。部署人工智慧系統來處理、儲存和分析這些資料會帶來重大的合規義務,涉及同意、資料最小化以及資料外洩通知等問題。此外,健康保險公司必須確保人工智慧驅動的決策流程符合可解釋性標準,尤其是在自動拒付受到監管審查的情況下。這些合規的複雜性增加了實施成本,並導致風險規避型保險公司和醫療保健系統在考慮大規模部署人工智慧時猶豫不決。
生成式人工智慧在預核准和拒絕管理自動化的應用
生成式人工智慧為醫療保健理賠管理領域的人工智慧帶來了突破性的機會。其潛力尤其巨大,能夠自動化核准前決策和不予批准申訴流程,而這些流程目前耗費臨床醫生和行政負責人大量時間。基於臨床指引和保險公司政策文件訓練的大規模語言模型,可在數秒內產生符合情境的準確核准建議。同樣,從醫療記錄中的臨床證據中提取的人工智慧產生的申訴信,能夠顯著提高不予批准理賠申請的撤銷率。
自動理賠審核中的演算法偏見和倫理問題。
使用人工智慧演算法審核、拒絕或協助審核保險索賠引發了人們對系統性偏見和醫療服務公平獲取的嚴重擔憂。如果訓練資料集反映了以往索賠處理中的不平衡,那麼由此產生的模型可能會使特定患者群體或醫療服務提供者類型遭受歧視性結果。美國醫療保險和醫療補助服務中心 (CMS) 和各州保險監管機構的監管力度正在加大,對演算法透明度和審計追蹤提出了新的要求。如果演算法偏見導致不公平的索賠被拒,那麼部署人工智慧審核工具的健康保險公司將面臨聲譽和法律風險。因此,健全的偏見測試程序和持續的模型管治計劃至關重要。
新冠疫情導致醫療保健索賠數量空前激增,其中包括一些現有系統難以處理的新型索賠,例如遠端醫療服務、新冠病毒檢測和疫苗接種。保險公司營運壓力巨大,索賠處理時間延長,加速了對人工智慧驅動的索賠自動化技術的投資。疫情凸顯了智慧平台的擴充性優勢,這些平台無需人工重新配置即可快速整合新的索賠代碼和處理規則,從而永久性地提升了人工智慧在整體收入周期環節中的戰略地位。
在預測期內,軟體領域預計將佔據最大的市場佔有率。
預計在預測期內,軟體領域將佔據最大的市場佔有率。這主要得益於保險公司、醫療服務提供者和第三方監管機構 (TPA) 對理賠處理自動化平台、詐欺偵測工具和收入週期管理解決方案的強勁且不斷成長的需求。企業級軟體的採用提供了一個高度擴充性且可配置的平台,能夠與現有的理賠管理系統和電子健康記錄(EHR) 基礎設施整合。向雲端原生 SaaS 交付模式的轉變降低了准入門檻,使中型保險公司和區域醫療系統無需進行大規模的本地 IT 投資即可利用先進的 AI 功能。
在預測期內,生成式人工智慧領域預計將實現最高的複合年成長率。
在預測期內,生成式人工智慧領域預計將呈現最高的成長率。這反映了生成式人工智慧在自動化複雜、語言密集理賠流程(包括預先批准、臨床文件審核以及針對拒賠決定的申訴)方面的巨大變革潛力。與傳統的基於規則的系統不同,生成式人工智慧模型能夠解讀非結構化的臨床記錄,提取相關的診斷證據,並在極少人工干預的情況下產生符合保險規定的核准回复。大規模語言模型部署成本的快速下降以及針對醫療保健行業的預訓練模型的日益普及,正在加速企業對該技術的採用。
在預測期內,北美預計將佔據最大的市場佔有率。這主要歸因於美國醫療保健報銷系統的複雜性和規模,該系統每年透過多個公共和私人支付管道處理超過1兆美元的理賠。高昂的理賠處理成本、嚴格的CMS(醫療保險和醫療補助服務中心)合規要求以及繁重的預核准流程,都為採用人工智慧技術提供了強力的商業理由。該地區受益於密集的醫療資訊技術供應商生態系統、數位醫療領域的大量創業投資投資以及促進理賠處理自動化創新的先進法規結構。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於中國、印度和東南亞私人健康保險市場的快速擴張。醫療保健支出不斷成長、受保人群不斷擴大以及政府主導的數位化醫療舉措,都催生了對高度擴充性的理賠管理基礎設施的需求。進入高成長新興市場的保險公司正在跳過舊有系統,從一開始就採用雲端原生人工智慧平台。與正在進行成本高昂的舊有系統現代化改造的成熟市場相比,這可以加快引進週期並降低整體擁有成本 (TCO)。
According to Stratistics MRC, the Global AI in Healthcare Claims Management Market is accounted for $4.1 billion in 2026 and is expected to reach $18.6 billion by 2034, growing at a CAGR of 20.7% during the forecast period. AI in AI in Healthcare Claims Management refers to the deployment of machine learning, natural language processing, and robotic process automation technologies to automate, validate, and optimize the processing of medical, pharmacy, dental, and hospital insurance claims. These solutions accelerate adjudication cycles, reduce administrative overhead, detect fraudulent submissions, and enhance denial prediction accuracy.
Escalating claims volumes and administrative cost pressures on payers and providers
The global healthcare system processes billions of insurance claims annually, with administrative costs consuming a disproportionate share of total healthcare expenditure. Manual claims adjudication is inherently error-prone, labor-intensive, and subject to compliance risks. AI-powered platforms drastically reduce processing time from days to minutes while improving accuracy through automated data validation and intelligent coding assistance. Payers facing competitive margin pressures and providers burdened with high denial rates are increasingly turning to AI solutions to streamline revenue cycles, accelerate cash flow, and reallocate skilled staff to higher-value activities.
Data privacy concerns and complex regulatory compliance requirements
Healthcare claims data is among the most sensitive categories of personal information, subject to stringent data protection frameworks including HIPAA in the United States and GDPR in Europe. Deploying AI systems that process, store, and analyze this data introduces significant compliance obligations around consent, data minimization, and breach notification. Healthcare payers must also ensure AI decision-making processes meet explainability standards, particularly when automated denials are subject to regulatory review. These compliance complexities increase implementation costs and create organizational hesitancy among risk-averse payers and health systems considering large-scale AI adoption.
Generative AI applications in automated prior authorization and denial management
Generative AI presents a landmark opportunity in AI in Healthcare Claims Management, particularly in automating prior authorization decisions and denial appeal processes that currently consume extensive clinician and administrative time. Large language models trained on clinical guidelines and payer policy documents can generate accurate, contextually appropriate authorization recommendations in seconds. Similarly, AI-generated appeal letters leveraging clinical evidence extraction from medical records significantly improve reversal rates for denied claims.
Algorithmic bias and ethical concerns in automated claims adjudication
The use of AI algorithms to make or support claims adjudication and denial decisions raises material concerns around systemic bias and equitable access to care. If training datasets reflect historical disparities in claims processing, resulting models may perpetuate discriminatory outcomes against certain patient demographics or provider types. Regulatory scrutiny from CMS and state insurance commissioners is intensifying, with new requirements for algorithmic transparency and audit trails. Healthcare payers deploying AI adjudication tools face reputational and legal exposure if algorithmic bias leads to unjust denials, necessitating robust bias testing protocols and ongoing model governance programs.
The COVID-19 pandemic generated an unprecedented surge in healthcare claims, including novel claim types for telehealth services, COVID-19 testing, and vaccine administration that existing systems were ill-equipped to process. Overwhelmed payer operations and extended adjudication backlogs spurred accelerated investment in AI-powered claims automation. The pandemic demonstrated the scalability advantages of intelligent platforms capable of rapidly incorporating new billing codes and processing rules without manual reconfiguration, permanently elevating the strategic priority of AI adoption across revenue cycle functions.
The software segment is expected to be the largest during the forecast period
The software segment is expected to account for the largest market share during the forecast period, , driven by strong and growing demand for claims processing automation platforms, fraud detection tools, and revenue cycle management solutions across payers, providers, and third-party administrators. Enterprise software deployments offer scalable, configurable platforms that integrate with existing claims management systems and EHR infrastructure. The shift toward cloud-native SaaS delivery models has lowered barriers to entry, enabling mid-sized payers and regional health systems to access sophisticated AI capabilities without extensive on-premise IT investment.
The Generative AI segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Generative AI segment is predicted to witness the highest growth rate, , reflecting its transformative potential in automating complex, language-intensive claims tasks such as prior authorization, clinical documentation review, and denial appeal generation. Unlike traditional rule-based systems, generative AI models can interpret unstructured clinical notes, extract relevant diagnostic evidence, and produce policy-compliant authorization responses with minimal human intervention. The rapidly declining cost of large language model deployment and growing availability of healthcare-specific pre-trained models are accelerating enterprise adoption.
During the forecast period, the North America region is expected to hold the largest market share, driven by the complexity and scale of the U.S. healthcare reimbursement system, which processes over a trillion dollars in annual claims through multiple public and private payer channels. High claims processing costs, stringent CMS compliance mandates, and substantial prior authorization burdens create compelling business cases for AI adoption. The region benefits from a dense ecosystem of health IT vendors, substantial venture capital investment in digital health, and progressive regulatory frameworks encouraging innovation in claims automation.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, propelled by rapid expansion of private health insurance markets in China, India, and Southeast Asia. Rising healthcare expenditure, growing insured populations, and government-led digital health initiatives are creating demand for scalable claims management infrastructure. Insurers entering high-growth emerging markets are bypassing legacy systems and adopting cloud-native AI platforms from inception, enabling faster deployment cycles and lower total cost of ownership compared to established markets undergoing costly legacy modernization.
Key players in the market
Some of the key players in AI in Healthcare Claims Management Market include International Business Machines Corporation, Oracle Corporation, Optum, Inc., Cognizant, Change Healthcare, Conduent Incorporated, EXL Service Holdings, Inc., Cotiviti, Inc., Wipro Limited, Infosys Limited, NVIDIA Corporation, HCL Technologies Limited, NTT DATA Group Corporation, FICO, SAS Institute Inc.
In March 2026, IBM Corporation announced an expansion of its Watson Health AI portfolio with a new generative AI module for claims denial management, enabling healthcare providers to automatically generate evidence-based appeal documentation by extracting relevant clinical data from electronic health records.
In February 2026, Optum, Inc. launched an enhanced AI-driven prior authorization platform integrated with real-time clinical decision support capabilities, enabling health plans to automate approval decisions for routine procedures while flagging complex cases for expedited clinical review.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.